You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML in first remission, first relapse or subsequent remission

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia
  • Venclexta 100 MG Oral Tablet
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023

Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)

Recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • Suzhou, Jiangsu, China
  • +1 more
Aug 18, 2022

Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Mitoxantrone hydrochloride liposome injection
  • +4 more
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Aug 15, 2023

First Manifestation of Steroid Sensitive Nephrotic Syndrome Trial in Paris (Levamisole Hydrochloride, Placebo)

Completed
  • First Manifestation of Steroid Sensitive Nephrotic Syndrome
  • Levamisole Hydrochloride
  • Placebo
  • Paris, France
    Hôpital Robert Debré
Jun 7, 2022

AML Patients After Stem Cell Transplant to Understand Relapse

Recruiting
  • Acute Myeloid Leukemia in Remission
  • Prospective determination of the clinical utility of measurable residual disease (MRD) testing
  • Duarte, California
  • +3 more
Dec 7, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Allogeneic Stem Cell Transplantation Trial in United States

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Boston, Massachusetts
  • +5 more
Oct 21, 2022

AML Trial in Moscow (allo-HSCT)

Recruiting
  • AML
  • allo-HSCT
  • Moscow, Russian Federation
    National Research Center for Hematology
Apr 14, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Blasts Under

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +3 more
  • Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 10, 2022

Acute Myeloid Leukemia Trial in Hefei (RC1012 injection (allo-DNT cells))

Recruiting
  • Acute Myeloid Leukemia
  • RC1012 injection (allo-DNT cells)
  • Hefei, Anhui, China
    The First Hospital of the University of Science and Technology o
May 17, 2023

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Lanzhou (Zanubrutinib)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Lanzhou, Gansu, China
    The First Hospital of Lanzhou University
Oct 23, 2022

Bipolar Disorder in Remission Trial in Hangzhou (Repetitive Transcranial magnetic stimulation and transcranial alternating

Recruiting
  • Bipolar Disorder in Remission
  • Repetitive Transcranial magnetic stimulation and transcranial alternating current stimulation
  • Hangzhou, Zhejiang, China
    Department of Psychiatry, First Affiliated Hospital of Zhejiang
Jul 20, 2023

Leukemia Trial (biological, drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • aldesleukin
  • +9 more
  • (no location specified)
Feb 17, 2022

Acute Myeloid Leukemia (AML) in Remission Trial in Washington (CPX-351)

Recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
May 3, 2022

Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

Completed
  • Fallopian Tube Cancer
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    Neuroblastoma Trial in New York (Hu3F8, GM-CSF, Isotretinoin)

    Active, not recruiting
    • Neuroblastoma
    • Hu3F8
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 1, 2022

    B Acute Lymphoblastic Leukemia Trial in Duarte (drug, procedure, other)

    Not yet recruiting
    • B Acute Lymphoblastic Leukemia
    • Autologous Anti-CD19 CAR-expressing T Lymphocytes
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Jan 30, 2023

    Acute Lymphoblastic Leukemia in Remission Trial in Suzhou (CD19 CAR-T cells and CD19 positive feeder T cells)

    Recruiting
    • Acute Lymphoblastic Leukemia in Remission
    • CD19 CAR-T cells and CD19 positive feeder T cells
    • Suzhou, Jiangsu, China
    • +2 more
    May 18, 2022

    Non-Alcoholic Fatty Liver Disease, Hyperuricemia Trial

    Not yet recruiting
    • Non-Alcoholic Fatty Liver Disease
    • Hyperuricemia
      • (no location specified)
      Feb 9, 2022

      Crohn's Disease, Ulcerative Colitis Trial (Samples)

      Not yet recruiting
      • Crohn's Disease
      • Ulcerative Colitis
      • Samples
      • (no location specified)
      Feb 8, 2023

      Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

      Not yet recruiting
      • Acute Lymphoid Leukemia
      • Acute Lymphoblastic Leukemia
      • CD19 Directed CAR T Cell
      • Aurora, Colorado
        University of Colorado Hospital
      Sep 12, 2022

      Neuroblastoma Trial in Worldwide (Naxitamab, GM-CSF, Isotretinoin)

      Recruiting
      • Neuroblastoma
      • Kowloon, Hong Kong
      • +8 more
      Jan 31, 2022

      Small Cell Lung Cancer Limited Stage Trial (Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy)

      Not yet recruiting
      • Small Cell Lung Cancer Limited Stage
      • Prophylactic cranial irradiation
      • +2 more
      • (no location specified)
      Dec 14, 2022

      CBF and/or NPM1-mutated AML in First Molecular Relapse.

      Recruiting
      • Acute Myeloid Leukemia
      • No intervention
      • Angers, France
        Angers University Hospital
      Jun 14, 2021

      Acute Myeloid Leukemia in Remission, MDS, Minimal Residual Disease Trial in Germany (Pevonedistat, Azacitidine)

      Active, not recruiting
      • Acute Myeloid Leukemia in Remission
      • +2 more
      • Aachen, Germany
      • +13 more
      Jul 11, 2022

      Acute Myeloid Leukemia (AML), MDS (MDS) Trial in China (APG-115, Azacitidine, Cytarabine)

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Myelodysplastic Syndromes (MDS)
      • Beijing, Beijing, China
      • +13 more
      Aug 16, 2022